Apixaban and Rivaroxaban Near Approval for Nonvalvular AF

April 2011
Internal Medicine Alert;4/15/2011 Supplement 2, p1
The article offers updates on medical topics in the U.S. including the near drug approval of apixaban and rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation, the forthcoming availability of fidaxomicin for treatment of Clostridia difficile infections, and issuance of a guideline from the American College of Physicians (ACP) for intensive insulin therapy.


Related Articles

  • Safety Analysis of Fidaxomicin in Comparison With Oral Vancomycin for Clostridium difficile Infections. Weiss, Karl; Allgren, Robin L.; Sellers, Sarah // Clinical Infectious Diseases;Aug2012 Supplement 2, Vol. 55 Issue suppl_2, pS110 

    Fidaxomicin is a novel macrocyclic antibiotic recently approved by the US Food and Drug Administration for the treatment of Clostridium difficile–associated diarrhea in adults. We reviewed safety data from nonclinical studies and clinical trials (phases 1, 2A, and 3) with fidaxomicin. In...

  • Fidaxomicin for C. difficile infections. Elliott, William T. // Primary Care Reports;Apr2011 Pharmacology Watch, p1 

    The article presents Fidaxomicin as a new option that will soon be available for the treatment of Clostridia difficile infections. Fidaxomicin was compared to vancomycin in a head-to-head Phase 3 noninferiority study of 629 adults where patients with a positive stool toxin test to C. difficile...

  • Apixaban and Rivaroxaban Near Approval for Nonvalvular AF.  // OB/GYN Clinical Alert;Apr2011 Clinical Brief, p1 

    The article offers information on several pharmacological reports in the U.S. It reports on pending approval of apixaban and rivaroxaban by the U.S. Food and Drug Administration (FDA) for the treatment of nonvalvular atrial fibrillation. It notes that fidaxomicin might be used as treatment for...

  • Do you recommend probiotics for children with C. diflicile? McFarland, Lynne V.; Wilcox, Mark // Infectious Diseases in Children;Aug2011, Vol. 24 Issue 8, p11 

    The article presents insights on the use of probiotics in children with Clostridium difficile infection.

  • Oritavancin Diphosphate. Cada, Dennis J.; Baker, Danial E. // Hospital Pharmacy;Dec2014, Vol. 49 Issue 11, p1049 

    Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on...

  • Fidaxomicin for C. difficile infections. Elliott, William T. // Neurology Alert;Apr2011 Clinical Bri, p1 

    The article presents information on a drug called fidaxomicin for the treatment of Clostridia difficile infections.

  • Not-so-super bug. Sims, Don // New Scientist;10/20/2007, Vol. 196 Issue 2626, p26 

    A letter to the editor is presented in response to the article about the antibiotic resistance of Clostridium difficile by James Kingsland, which appeared in a previous issue.

  • Fidaxomicin minimally absorbed, even in severe C. diflicile.  // Infectious Disease News;Jun2011, Vol. 24 Issue 6, p9 

    The article reports on a study which indicated that fidaxomicin is minimally absorbed in patients with Clostridium difficile.

  • The Search for a Better Treatment for Recurrent Clostridium difficile Disease: Use of High-Dose... Surawicz, Christina M.; McFarland, Lynne V.; Greenberg, Richard N.; Rubin, Moshe; Fekety, Robert; Mulligan, Maury E.; Garcia, Reuben J.; Brandmarker, Sally; Bowen, Karen; Borjal, Delia; Elmer, Gary W. // Clinical Infectious Diseases;10/1/2000, Vol. 31 Issue 4, p1012 

    Reports on the effect of a short course of treatment with high-dose vancomycin in combination with Saccharomyces boulardii on the prevention of subsequent recurrences of Clostridium difficile disease (CDD). Finding that CDD is the most frequently identified cause of nosocomial diarrhea, colitis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics